The positions in the table below reflect the Allied Clinical Trials, Inc.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Arvinas plans Phase 3 trials for vepdegestrant combinations in breast cancer and initiates trials for new Parkinson's disease treatments. Arvinas, Inc. announced its plans to begin two Phase 3 ...
Science 37’s Operating System to enhance Worldwide Clinical Trials’ approach to decentralized clinical trials for faster enrollment, better retention, and more representative solutions RESEARCH ...
RESEARCH TRIANGLE PARK, N.C. & MALMÖ, Sweden--(BUSINESS WIRE)--Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsized, full-service contract research organization (CRO), ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), announced today ...
Worldwide Clinical Trials Inc. is aiming to hire dozens of workers for a $10 million expansion to its Austin, Texas, lab, the Austin Business Journal reported Aug. 24. The company recently added a ...
WARSAW, Poland, Jan. 4, 2023 /PRNewswire/ -- Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO, reiterates its commitment to advancing ...
Case Western Reserve University-developed imaging agent for MRI prostate cancer detection gets FDA approval for safety trials, set to begin in May in Columbus CLEVELAND--The U.S. Food and Drug ...
Good day, and welcome to the TX45 Phase Ib Part B PH-HFrEF data conference call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Dr. Alise ...
Good morning, ladies and gentlemen, and welcome to the Eledon Pharmaceuticals Phase II BESTOW Results Conference Call. [Operator Instructions] This call is being recorded on Friday, November 7, 2025.